Myovant Sciences Ltd. — key financial figures for fiscal year 2021 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2021)

$231.0M

Net Income/Loss (FY2021)

-$206.0M

Total Assets (FY2021)

$520.0M

Total Equity (FY2021)

-$473.5M

Cash Flows from Operating Activities (FY2021)

-$268.6M

Source: Myovant Sciences Ltd. 10-K filing (FY2021). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.